ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for ALVO

Stock NameAlvotech
TickerALVO(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINLU2458332611

Show aggregate ALVO holdings

News associated with ALVO

Alvotech Reports Positive CHMP Opinion For Gobivaz
(RTTNews) - Alvotech (ALVO) and Advanz Pharma Holdco announced that the European Medicines Agency's Committee for Medicinal Products for Human use has adopted a positive opinion recommending approval for Gobivaz, Alvotech's proposed biosimilar to Simponi, a biologic used to treat - 2025-09-22 06:03:00
Alvotech (NASDAQ:ALVO) Short Interest Update
Alvotech (NASDAQ:ALVO – Get Free Report) was the recipient of a significant increase in short interest in the month of August. As of August 15th, there was short interest totaling 1,970,000 shares, anincreaseof77.5% from the July 31st total of 1,110,000 shares. Currently,1.8% of the shares of the company are sold short. Based on an average […] - 2025-09-08 04:52:49
After-Hours Earnings Report for August 13, 2025 : CSCO, COHR, STN, EQX, ALVO, FIHL, RNW, DLO, IBTA, SUPV, ASM, CCAP
The following companies are expected to report earnings after hours on 08/13/2025. Visit our Earnings Calendar for a full list of expected earnings releases.Cisco Systems, Inc. (CSCO)is reporting for the quarter ending July 31, 2025. The computer networks company's consensus ear - 2025-08-13 15:00:01
Alvotech (NASDAQ:ALVO) Short Interest Update
Alvotech (NASDAQ:ALVO – Get Free Report) was the target of a significant increase in short interest during the month of May. As of May 31st, there was short interest totalling 1,550,000 shares, an increase of 75.2% from the May 15th total of 884,700 shares. Based on an average daily volume of 188,500 shares, the days-to-cover […] - 2025-06-16 04:48:48
B. Riley Wealth Advisors Inc. Sells 39,605 Shares of Alvotech (NASDAQ:ALVO)
B. Riley Wealth Advisors Inc. lessened its stake in shares of Alvotech (NASDAQ:ALVO – Free Report) by 79.2% in the 4th quarter, Holdings Channel reports. The firm owned 10,395 shares of the company’s stock after selling 39,605 shares during the period. B. Riley Wealth Advisors Inc.’s holdings in Alvotech were worth $138,000 at the end […] - 2025-06-02 05:57:03
Vident Advisory LLC Buys New Shares in Alvotech (NASDAQ:ALVO)
Vident Advisory LLC acquired a new position in shares of Alvotech (NASDAQ:ALVO – Free Report) in the fourth quarter, HoldingsChannel.com reports. The firm acquired 20,272 shares of the company’s stock, valued at approximately $268,000. Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. PointState Capital […] - 2025-05-30 05:03:02
Alvotech Announces Successful Listing of Swedish Depository Receipts on Nasdaq Stockholm
Alvotech announced a successful oversubscribed offering of Swedish Depository Receipts, commencing trading on Nasdaq Stockholm. - 2025-05-19 03:40:27
Barclays PLC Makes New $210,000 Investment in Alvotech (NASDAQ:ALVO)
Barclays PLC acquired a new position in Alvotech (NASDAQ:ALVO – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 15,860 shares of the company’s stock, valued at approximately $210,000. Other hedge funds also recently modified their holdings of the company. Wolverine Asset Management […] - 2025-05-13 04:34:47
Alvotech (NASDAQ:ALVO) & Krystal Biotech (NASDAQ:KRYS) Critical Contrast
Alvotech (NASDAQ:ALVO – Get Free Report) and Krystal Biotech (NASDAQ:KRYS – Get Free Report) are both mid-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, institutional ownership, analyst recommendations, risk, valuation, dividends and profitability. Valuation and Earnings This table compares Alvotech and […] - 2025-05-09 02:38:57
11,210 Shares in Alvotech (NASDAQ:ALVO) Purchased by Invesco Ltd.
Invesco Ltd. acquired a new stake in shares of Alvotech (NASDAQ:ALVO – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 11,210 shares of the company’s stock, valued at approximately $148,000. Other large investors also recently modified their holdings of the company. Geode […] - 2025-05-05 04:40:48
Legal & General Group Plc Cuts Holdings in Alvotech (NASDAQ:ALVO)
Legal & General Group Plc reduced its holdings in shares of Alvotech (NASDAQ:ALVO – Free Report) by 42.2% during the fourth quarter, HoldingsChannel reports. The firm owned 576,189 shares of the company’s stock after selling 420,869 shares during the period. Legal & General Group Plc’s holdings in Alvotech were worth $7,349,000 as of its most […] - 2025-04-20 04:56:53

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) ALVO holdings

DateNumber of ALVO Shares HeldBase Market Value of ALVO SharesLocal Market Value of ALVO SharesChange in ALVO Shares HeldChange in ALVO Base ValueCurrent Price per ALVO Share HeldPrevious Price per ALVO Share Held
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ALVO by Blackrock for IE00BYXG2H39

Show aggregate share trades of ALVO

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-06BUY1,5548.5808.610 8.607USD 13,375 9.99
2025-10-03BUY3,6198.3208.330 8.329USD 30,143 10.00
2025-10-02BUY5178.2008.220 8.218USD 4,249 10.01
2025-09-30BUY1,0348.1908.360 8.343USD 8,627 10.03
2025-09-26BUY1,0348.3408.380 8.376USD 8,661 10.04
2025-09-25BUY1,0348.1208.550 8.507USD 8,796 10.06
2025-09-24BUY16,3598.5808.940 8.904USD 145,661 10.06
2025-09-18BUY4697.8208.000 7.982USD 3,744 10.08
2025-09-17BUY1,4137.9308.020 8.011USD 11,320 10.09
2025-09-11SELL-4708.0508.150 8.140USD -3,826 10.14 Profit of 938 on sale
2025-09-10BUY9408.0308.160 8.147USD 7,658 10.15
2025-09-05SELL-4698.3308.405 8.397USD -3,938 10.18 Profit of 837 on sale
2025-08-29SELL-1,4108.0708.110 8.106USD -11,429 10.24 Profit of 3,002 on sale
2025-08-27BUY9388.0308.110 8.102USD 7,600 10.26
2025-08-26SELL-4698.1208.300 8.282USD -3,884 10.28 Profit of 935 on sale
2025-08-25BUY4698.3208.555 8.532USD 4,001 10.29
2025-08-20SELL-1,8728.2208.590 8.553USD -16,011 10.31 Profit of 3,294 on sale
2025-08-18BUY9369.0009.010 9.009USD 8,432 10.33
2025-08-08SELL-9368.4608.550 8.541USD -7,994 10.39 Profit of 1,729 on sale
2025-08-05BUY4678.6208.898 8.870USD 4,142 10.43
2025-08-01SELL-1,3998.7909.060 9.033USD -12,637 10.45 Profit of 1,980 on sale
2025-07-30BUY5,2619.2809.730 9.685USD 50,953 10.47
2025-07-17SELL-9168.7308.760 8.757USD -8,021 10.56 Profit of 1,647 on sale
2025-07-11SELL-3,6648.5208.800 8.772USD -32,141 10.62 Profit of 6,758 on sale
2025-07-07BUY1,3749.0209.260 9.236USD 12,690 10.67
2025-07-02BUY25,1908.9309.095 9.079USD 228,687 10.71
2025-06-25BUY9169.1309.280 9.265USD 8,487 10.76
2025-06-20SELL-13,3299.3509.400 9.395USD -125,226 10.80 Profit of 18,729 on sale
2025-06-13BUY2,7709.7409.799 9.793USD 27,127 10.87
2025-06-11BUY99010.11010.320 10.299USD 10,196 10.88
2025-06-10BUY99010.37010.630 10.604USD 10,498 10.89
2025-06-04SELL-49510.83011.850 11.748USD -5,815 10.90 Loss of -420 on sale
2025-04-23BUY4958.3608.750 8.711USD 4,312 11.41
2025-04-10SELL-3,9608.2008.850 8.785USD -34,789 11.82 Profit of 12,024 on sale
2025-04-08SELL-4958.0608.890 8.807USD -4,359 11.93 Profit of 1,545 on sale
2025-04-07SELL-4958.3208.700 8.662USD -4,288 11.99 Profit of 1,645 on sale
2025-04-04SELL-2,4758.5008.880 8.842USD -21,884 12.04 Profit of 7,919 on sale
2025-04-01BUY2,0649.6409.900 9.874USD 20,380 12.13
2025-03-31SELL-1,4889.6709.690 9.688USD -14,416 12.17 Profit of 3,695 on sale
2025-03-21BUY22,70711.57011.680 11.669USD 264,968 12.30
2025-03-14SELL-6,72011.30011.450 11.435USD -76,843 12.40 Profit of 6,457 on sale
2025-03-07SELL-84011.15011.280 11.267USD -9,464 12.55 Profit of 1,080 on sale
2025-03-04SELL-42010.81011.000 10.981USD -4,612 12.66 Profit of 707 on sale
2025-02-25BUY84011.82011.885 11.879USD 9,978 12.83
2025-02-19SELL-41911.72012.400 12.332USD -5,167 12.95 Profit of 259 on sale
2025-02-13BUY1,25712.78012.825 12.820USD 16,115 12.97
2025-02-12BUY41912.65012.960 12.929USD 5,417 12.98
2025-02-11BUY1,67612.68012.840 12.824USD 21,493 12.99
2025-01-17BUY1,67613.27013.460 13.441USD 22,527 13.27
2025-01-16BUY1,67613.23013.480 13.455USD 22,551 13.27
2025-01-10SELL-83813.52013.690 13.673USD -11,458 13.22 Loss of -380 on sale
2025-01-08SELL-1,67613.25013.450 13.430USD -22,509 13.16 Loss of -453 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ALVO

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1959,725650110,49254.1%
2025-09-1880,4030179,85844.7%
2025-09-1748,160083,34657.8%
2025-09-1639,03438868,41057.1%
2025-09-1544,198070,52262.7%
2025-09-1245,75910070,46064.9%
2025-09-1146,061084,72954.4%
2025-09-1054,878088,96461.7%
2025-09-0939,0328096,53140.4%
2025-09-0862,034883134,54146.1%
2025-09-0555,3970176,81731.3%
2025-09-0438,456380,83947.6%
2025-09-0398,2600139,88770.2%
2025-09-02112,6640199,69256.4%
2025-08-2949,300081,90460.2%
2025-08-2875,3280113,91766.1%
2025-08-27117,046270190,65061.4%
2025-08-2691,9940131,30570.1%
2025-08-25101,7530146,76469.3%
2025-08-2292,3560237,98238.8%
2025-08-21153,0370235,54865.0%
2025-08-20105,2260152,47869.0%
2025-08-19119,6630207,74457.6%
2025-08-18263,5151576,46045.7%
2025-08-15144,7228,898242,28459.7%
2025-08-14363,52171,227647,64656.1%
2025-08-13166,1220254,60465.2%
2025-08-1269,5410109,73963.4%
2025-08-1164,766072,17789.7%
2025-08-0847,018053,26788.3%
2025-08-0759,998071,09984.4%
2025-08-0691,6680115,34879.5%
2025-08-0548,99679260,29781.3%
2025-08-0448,606076,56863.5%
2025-08-0172,3600106,55567.9%
2025-07-3169,8330109,27163.9%
2025-07-3075,699393126,49159.8%
2025-07-2983,7890107,55477.9%
2025-07-2885,9470107,67379.8%
2025-07-2561,2321147,24841.6%
2025-07-2440,797063,63164.1%
2025-07-2374,6530177,97941.9%
2025-07-2246,284068,55767.5%
2025-07-2171,051099,32871.5%
2025-07-1859,058079,33074.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy